CHRNA7 and Sepsis: Furthermore, in the present study, we proved that delayed administration with a selective α7nAChR agonist GTS-21 enables a more efficient elimination of the offending pathogen, diminished inflammatory response and organ injury, and improved survival rates in the CLP-induced polymicrobial sepsis model.